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Introduction 
Pharmacists play a crucial role in maximizing public health by being an accessible resource for patients of all populations. Pharma-
cists can educate their patients on the numerous benefits of vaccines and promote their administration, especially within high-risk 
populations. Most pharmacies today offer clinic hours where patients can receive their annual influenza vaccine; many also offer 
additional options such as the shingles vaccine. With vaccinations becoming an easy trip to the local pharmacy, one major barrier 
for immunizations has been eliminated, further opening the door toward maximum disease prevention. Every year, hospitals are 
ridden with patients suffering from preventable diseases and, while it seems unfathomable in our present-day society, people still 
die from diseases like influenza every winter. It is the pharmacists' role to educate on the simplicity and necessity of basic vaccina-
tions. The vaccinations discussed in this article are a vital element in preventing disease states that can include a range of 
symptoms and complications which can vary from the inconvenience of keeping one away from their daily responsibilities for a 
short period of time to a potential precursor to cancer. There are five vaccinations in particular which target common transmittable 
disease states: human papillomavirus (HPV); diphtheria, tetanus, and pertussis; hepatitis B; herpes zoster virus (shingles); and influ-
enza. The objective of this article is to provide pharmacists with the necessary information to properly educate, advise, and encour-
age their patients about common vaccinations that could have a significant effect on positively altering their long-term health and 
quality of life. 
Human Papillomavirus (HPV) Vaccine 
The HPV vaccine is a recombinant subunit vaccine administered to prevent the subtypes of HPV that are known to commonly cause 
cervical cancer and genital warts. 1 There are currently two HPV vaccines available: Gardasii9, a quadrivalent vaccine containing viral 
types 6, 11, 16 and 18, and Cervarix°, a bivalent vaccine containing types 6 and 18. Both vaccines are given intramuscularly (IM) as 
a three-dose series; the second dose to be given one to two months after the first and the third dose to be given six months after 
the first dose.2 Females age 9 to 26 years are recommended to receive either of the vaccines to protect against cervical cancer. 
Gardasi1° has also been proven safe and effective for males age 9 to 26 years for the prevention of genital warts. The CDC recom-
mends that males 22 through 26 years of age whose immune systems are weakened, who have sex with men, or who test positive 
for the human immunodeficiency virus (HIV), should receive this vaccination. The quadrivalent vaccine is also recommended for all 
boys at age 11 or 12 and catch-up vaccinations for males age 13 through 21years. 3 Because sexually active patients are thought to 
benefit most from the vaccine, and a patient can be infected with HPV the first time they have sexual contact with a partner, it is 
important to get all three doses before being exposed to the virus to ensure protection. 1 
The HPV vaccine is contraindicated in patients who are allergic to yeast or any component of the vaccine and should not be given 
to a patient who is ill at the time a dose is planned. Neither formulation of the vaccine is recommended to be administered to preg-
nant women. Gardasil• can, however, be administered to nursing mothers. 2 Side effects of the vaccine include pain, redness and 
swelling at the injection site. Mild to moderate fever and headache have also been reported. While many private health plans are 
providing coverage for the HPV vaccine, the level of coverage can vary. Those patients who are uninsured or whose insurance does 
not pay for the vaccine may qualify for assistance programs such as Vaccines for Children (VFC) or patient assistance programs 
through the companies that supply the vaccines. 1 
Diphtheria, Tetanus and Pertussis Vaccines 
The four combination vaccines associated with the prevention of diph-
theria, tetanus and pertussis are DTaP, Tdap, DT and Td. DT and Td con-
tain both the diphtheria toxoid and the tetanus toxoid, while DTaP and 
Tdap contain an additional dose of killed, acellular pertussis. 2 All four 
vaccines are administered IM, however there are different recommen-
dations as to when they should be administered. 1 
DTaP and DT are given to children younger than 7 years of age. These 
children should receive five doses of DTaP: at ages 15 to 18 months, 2 
years, 4 years, and 6 years, and any time between 4 and 6 years. DT 
should be used as a substitute for children who cannot tolerate the per-
tussis vaccine. DTaP and DT are contraindicated in anyone who is 7 years 
of age or older, is allergic to any component of the vaccine and has a 
moderate to severe illness on the day the vaccine is scheduled. Side ef-
fects of DTaP and DT include redness and swelling at the injection site, 
fever and seizures. 1 
Tdap and Td are given to adults and children 7 years of age and older. Td 
is given as a booster shot every 10 years to unvaccinated and previously 
vaccinated adults. Patients presenting with a major wound or exposure 
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to tetanus more than five years after their last injection 
should also be revaccinated. 2 A single dose of Tdap 
should be given in place of Td booster in anyone 11 to 
64 years of age, and in children 7 to 10 years old who 
are underimmunized or did not receive the full recom-
mended series of DTaP before age 7 years. Adults 65 
years of age and older should also receive one dose of 
Tdap if they are likely to come into contact with an in-
fant younger than 12 months.4 Tdap and Td are contra-
indicated in anyone with an allergy to any component 
Pharma]et® is the newest technology in 
influenza vaccinations; it is a needle-free 
injection system that uses a spring-powered 
energy source to administer the vaccination 
without actually puncturing the skin. 
of the vaccine and those individuals suffering from a ----------------------------
moderate to severe illness on the day the vaccine is scheduled. 1 The Tdap vaccine is now recommended for women in the third or 
late second trimester (20th week or more) of their pregnancy. 3 
Side effects of Tdap and Td include redness and swelling at the injection site, body aches and fever. 2 Most private health plans are 
providing coverage for all four of the diphtheria, tetanus and pertussis vaccines. Again, those patients who are uninsured may qual-
ify for assistance programs such as VFC or discounted vaccines at their local health department. 1 
Hepatitis B Vaccine 
The Hepatitis B vaccine is produced by yeast and contains a viral envelope protein, hepatitis B surface antigen (HBsAg). It is indi-
cated for use in patients who are health care workers and those with chronic liver diseases as well as end-stage renal disease, 
MSM, patients with multiple sexual partners, or HIV-infected patients without immunity. Changes in the Centers for Disease Con-
trol and Prevention (CDC) guidelines for 2012 recommend that adults recently diagnosed with diabetes who are younger than 60 
years old should receive the Hepatitis B vaccine as soon as possible. 3 However, it should be given to any adult who desires the vac-
cine. Post-vaccination serologic testing should be done on patients who are considered to be at high risk, such as health care work-
ers. If the patient does not respond according to serum levels, the patient should be revaccinated. 2 The vaccine is given in three 
doses: at intervals of 0, 1, and 6 to 12 months. 1 If the series is not completed, it is not a requirement that it be restarted. However, 
it is recommended that the patient contact his/her medical provider about the situation. 5 The vaccine is administered IM and 
should be used with caution if the patient has yeast allergies. 2The vaccine itself is safe to administer to pregnant women and has 
had almost no adverse effects reported in over 100 million administrations. Booster shots are not recommended for healthy pa-
tients but can be used in hemodialysis patients or patients with a weakened immune system. This vaccine may also be taken in 
conjunction with other vaccines. 5 
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Influenza Vaccine 
There are two forms of the vaccination available to target this 
unpredictable and highly contagious respiratory illness. Infection 
with influenza is caused by one of thousands of strains of this 
virus that infects the nose, throat and lungs. Each year, the U.S. 
Food and Drug Administration (FDA} selects which viruses to 
target for that particular year according to the recommendations 
from the World Health Organization (WHO}. The 2011-2012 vac-
cination for the Northern Hemisphere targets these three vi-
ruses: an A/California/7 /2009 (H1N1)-like virus, an A/ 
Perth/16/2009 (H3N2)-like virus, and a B/Brisbane/60/2008-like 
virus (Influenza B). 1 
What many Americans think of as the traditional "flu shot" is a 
trivalent inactivated vaccine (TIV) and can be one of three sub-
categories: a regular IM flu shot indicated for all ages over 6 
months (Fluzone °), a high dose IM shot indicated for patients 
over 65 years (Fluzone" High-Dose}1 [higher dose is not 
preferred2] and an intradermal shot indicated for patients ages 
18 to 64 (Fluzone·-lntradermal).1 These vaccinations are accept-
able for administration to pregnant women and result in minimal 
side effects, with the most common being irritation at the injec-
tion site, a low-grade fever and/or muscle aches (generally last-
ing 1 to 2 days).2 
The other available form is a live attenuated influenza 
vaccine (LAIV} administered via the intranasal route 
(Flumist"). This is indicated for non-pregnant, healthy 
adults 49 years and younger and can cause some mi-
nor adverse reactions, most commonly nasal conges-
tion, headache and/or cough.2 This form is an excel-
lent alternative for patients who are uncomfortable 
with needles. While no studies specifically focusing on 
influenza have been done for an adult population, one 
large study of children age 15 to 85 months concluded 
a 92 percent decrease in chance of influenza infection 
versus placebo with the LAIV vaccine.1 
Following administration of either vaccine, it takes 
approximately two weeks for the proper antibodies to 
develop and infer protection from the influenza virus. 1 
Neither vaccination is recommended for patients with 
a history of Guillain-Barre Syndrome.1 While in the 
~~~~~ ............ '--=~ 
past, patients with chicken egg allergies have refrained from receiving the vaccine, the CDC's Advisory Committee on Immunization 
Practices (ACIP} has made a recommendation based upon several thorough studies stating that people who have experienced hy-
persensitivity reactions which manifested as only hives following egg consumption can receive TIV intramuscularly as long as it is 
administered by a health care professional familiar with the manifestations of egg allergies who can observe the patient for 30 min-
utes post-administration. 1 
PharmaJet • is the newest technology in influenza vaccinations; it is a needle-free injection system that uses a spring-powered en-
ergy source to administer the vaccination without actually puncturing the skin. 6 However, the FDA released a statement on Octo-
ber 26, 2011, clarifying that inactivated influenza vaccines labeled for IM injection are only labeled for administration using a sterile 
needle and syringe.7 Their statement explained that the necessary safety and effectiveness information has not been submitted to 
the FDA and therefore there is no definitive information to support approval of this injection system. Currently, Measles, Mumps, 
Rubella (MMR) is the only vaccination approved and specifically labeled for administration via a jet injector.7 
The ACIP recommends a yearly flu vaccination for everyone six months of age and older, but especially for seniors over 65, preg-
nant women, and those with health conditions like diabetes, asthma or heart disease. 3 These groups are at high risk for serious flu-
related complications. Children ages 6 months through 8 years are recommended to receive two doses of the flu vaccine four or 
more weeks apart (unless they received the vaccination last season). 1 The first dose will "prime" the immune system and the sec-
ond dose 28 days or more later will provide the true immune protection. 1 
Zostavax" 
Zostavax" is a live attenuated virus vaccine administered as a one-time 
subcutaneous dose for use in adults over the age of 60. It is not recom-
mended for use in immunocompromised, gelatin sensitive or pregnant 
patients. The main goal of Zostavax" is to prevent shingles, a disease 
that is more likely to be seen in older patients who have lost their im-
mune system efficiency. The vaccine has been tested in about 20,000 
~·--.;;.. ... ~ people aged 60 years old and older. The most common side effects 
that were observed were redness, soreness, swelling or itching local-
ized at the injection site and headache. 2 Patients should space this vac-
cine at least four weeks apart from the pneumococcal vaccination to 
ensure they receive the maximum efficacy from both vaccinations. 8 
Any patients using acyclovir, famciclovir, or valacyclovir should cease 
taking their medication for at least 24 hours before getting Zostavax •. 2 
While the usage of the vaccine is recommended for those above 60, it 
is FDA approved for use in those over 50 if deemed medically needed. 
The vaccine itself is not covered by Medicare Part B. Private insurances 
and Medicaid may cover the vaccine. 8 Currently there are no programs 
available to help patients purchase Zostavax" in the event of no cover-
age. 
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Vaccine Indications Route Frequency Contraindications Adverse Reactions 
HPV Males and females 
aged 9-26 years Allergy to yeast or Injection site pain, (Gardasil 0 ) 3 doses; 0, 1-2, and 6 IM 
months 
vaccine component, redness, swelling 
Females aged 9-26 pregnancy fever, headache 





5 doses; 15-18 months, ;:: 7 years, allergy to Injection site 
• DTaP and DT Children < 7 years 2, 4, 4-6, 6 years vaccine component, redness, swelling 
illness fever, seizure 
Adults and children Once in place of Td Allergy to vaccine Injection site 
• Tdap 
;:: 7 years,< 65 IM booster component, illness redness, swelling years fever, body aches 
Injection site 
• Td 
Adults and children IM Booster every 10 years 
Allergy to vaccine redness, swelling 





liver disease, end- Injection site 
Hepatitis B stage renal disease, IM 3 doses; 0, 1, and 6-12 Yeast allergy 
swelling, warmth, 
MSM, multiple months soreness, nodule 






Allergy to vaccine Injection site 
• Trivalent Adults and children Once at the beginning component, history irritation, Inactivated IM of Guillain-Barre low grade fever, 
(TIV) > 6 months of every flu season Syndrome, severe body aches 
egg allergy (lasting 1-2 days) 
Allergy to vaccine 
• Live 
Children> 2 years, component, 
Attenuated 
non-pregnant and Intra- Once at the beginning pregnancy, history Nasal congestion, 
(LAIV) healthy adults < 49 nasal of every flu season of Guillain-Barre headache, cough years Syndrome, egg allergy 
-- - ·---
--- ---- -- --
lmmunocompro- Injection site 
Zostavax 
. 
Adults> 60 years SC Once mised, gelatin allergy, soreness, swelling, 
pregnancy itching, headache 
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Pneumococcal Vaccine 
The U.S. Food and Drug Administration (FDA) recently approved of Prevnar 13, a pneumococcal vaccine, for use in adults age 50 
years and older. Although CDC recommends that those age 65 and older and those age 19 through 64 with certain health condi-
tions get another pneumococcal vaccine called Pneumovax, CDC has not issued any formal recommendation concerning Prevnar 13. 3 
Additionally, Prevnar 13 is approved for use in children 6 weeks 
through 5 years of age (prior to the sixth birthday) for active 
immunization. Prevnar 13 is also indicated for the prevention of 
otitis media caused by streptococcus pneumoniae serotypes 4, 68, 
9V, 14, 18C, 19F, and 23F. No otitis media efficacy data are avail-
able for serotypes 1, 3, 5, 6A, 7F, and 19A.9 
Conclusion 
Pharmacy is a dynamic profession, 
continuously adapting to meet the 
needs of our present day society. 
Pharmacy is a dynamic profession continuously adapting to meet the needs of our present day society. By utilizing the convenience 
and accessibility of pharmacists, more patients in more populations can be immunized and protected from preventable disease 
states. It is crucial to educate all patients on the long term health benefits of a simple vaccination and how it can improve their 
quality of life. HPV, DTaP, hepatitis B, herpes zoster and influenza vaccines are a great foundation to maximizing public health, and 
expanding one's knowledge to other vaccinations can only Improve the care for patients overall . 
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